Otolaryngology Doctors in Gurnee, IL Accepting Medicare

5 Otolaryngology doctors found. Showing 1 - 5

Dr. Geoffrey Michael Schwartz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 222 S Greenleaf St Ste 102, Gurnee, IL 60031 Phone: 847-662-4442    Fax: 847-662-4446

Benjamin C Johnson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 222 S Greenleaf, Lake County Head & Neck Specialists Sc Suite 106, Gurnee, IL 60031 Phone: 847-662-4442    Fax: 847-662-4446

Dr. Vibhakar Shantilal Shah, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 222 S Greenleaf St, Suite No. 109, Gurnee, IL 60031 Phone: 847-249-0167    Fax: 847-249-0717

Narendra M Desai, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 222 S Greenleaf St Ste 102, Gurnee, IL 60031 Phone: 847-662-4442    Fax: 847-662-4446

Erik G Nelson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 222 S Greenleaf, Ste 106, Gurnee, IL 60031 Phone: 847-662-4442    Fax: 847-662-4446

News Archive

Integra launches CRW Precision Arc Stereotactic System for neurosurgery

Integra LifeSciences Holdings Corporation announced today the launch of the CRW Precision™ Arc Stereotactic System, a multi-purpose stereotactic system used for localizing intra-cranial targets and precisely directing instruments to the target in cases such as brain biopsy, tumor resection, and Deep Brain Stimulation (DBS) surgeries.

Depression remains two times more likely in children with brain injury or concussion

​Adults with head injuries are known to be at high risk for depression, and yet little research had been done on the topic related to children. In the abstract, "Depression in Children Diagnosed with Brain Injury or Concussion," presented Oct. 25 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Orlando, researchers sought to identify the prevalence of depression in children with brain injuries, including concussions, in the U.S.

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

Shire plc today announced that Natpara (parathyroid hormone) for injection is now available in the United States. The U.S. Food and Drug Administration approved Natpara as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism on January 23, 2015.

PTC Therapeutics initiates reimbursed expanded access program for Translarna

PTC Therapeutics, Inc. today announced the initiation of a reimbursed expanded access program (EAP). PTC's EAP program is intended to make Translarna (ataluren) available to patients before commercial availability in certain countries.

Studies uncover impacts of contaminants on Arctic inhabitant's health

People living in Arctic areas can be more sensitive to pollutants due to their genetics, says researcherArja Rautio at the Centre for Arctic Medicine in theUniversity of Oulu, Finland.

Read more Medical News

› Verified 2 days ago